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ABSTRACT
Many  people  living  with  chronic  conditions  have  multiple  chronic  conditions. 
Multimorbidity  is  defined  here  as  the  co-existence  of  two  or  more  chronic 
conditions, where one is not necessarily more central than the others. Multimorbidity 
affects quality of life, ability to work and employability, disability and mortality.   
Currently, clinicians have limited guidance or evidence as to how to approach care 
decisions for such patients. Understanding how to best care and design the health 
system for patients with multimorbidity may lead to improvements in quality of 
life, utilization of healthcare, safety, morbidity and mortality.  The objective of this 
paper is to review the implications of multimorbidity for the design of health system 
and to understand the research needs for this population. The consideration of 
people  with  multimorbidity  is  essential  in  the  design  and  evaluation  of  health 
systems. Fundamentally, people with multimorbidity should receive a patient - and 
family-centered approach to care throughout the health system, and understanding 
how to deliver this type of care in effective and efficient ways is an enormous 
challenge, and opportunity, for clinicians, researchers, and policy makers today.
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INTRODUCTION
Approximately one in four adults have two or more chronic conditions, and 
half of older adults have three or more chronic conditions.1-5 The prevalence 
of multiple chronic conditions (MCC) among individuals increases with 
age and is substantial among older adults, even though many people with 
MCC are under the age of 65 years.5 The number of individuals with MCC 
will increase dramatically in coming years.1 Comorbidity is increasingly 
recognized as a critical clinical issue in medical care, in part because it is 
an independent predictor of adverse outcomes, including quality of life 
(QOL), mortality, healthcare, disability, and complications of treatment 
beyond  the  effects  of  the  individual  conditions.6-22  Most  research  and 
clinical care has considered comorbidity from the perspective of an index 
condition. In the presence of multiple conditions this perspective becomes 
an inefficient and perhaps ineffective framework for management of all the 
chronic conditions of a single person, and may be equally flawed for a 
health system’s approach to people with MCC.23 The term multimorbidity, 
capturing  multiple,  potentially  interacting,  medical  and  psychiatric 
conditions, may be more appropriate and more patient-centered for the 
older population than consideration from the perspective of a single index 
condition, which is the traditional approach.24,25 Currently, clinicians have 
limited guidance or evidence as to how to approach care decisions for such 
patients.26 Understanding how to best care and design the health system for 
patients with multimorbidity may lead to improvements in QOL, utilization 
of healthcare, safety, morbidity and mortality.27 The objective of this paper 
is to review the implications of multimorbidity for the design of health 
systems and to understand the research needs for this population. 
DEFINITIONS OF COMORBIDITY, MULTIMORBIDITY,  
AND COMPLEXITY
Feinstein defined comorbidity as “any distinct additional clinical entity that 
has existed or may occur during the clinical course of a patient who has the 
index disease under study.”28 By definition, this assumes that one is taking 
an index disease perspective, with one disease assuming a central place 
(Figure 1). The usefulness of a framework where one disease is considered 
central is not clear when considering the optimal care and health system for 
people with multimorbidity, unless one disease is truly dominant in terms 
of the care and well-being of the individual.4,26,29 Future of Multimorbidity Research  453
Fig. 1. Conceptual Diagram of Comorbidity: Index Disease, With One or More 
Comorbid  Condition  or  Diseases  Affecting  Its  Course  and  Treatment. 
Comorbidity  has  often  been  studied  and  treated  in  clinical  practice  from  the 
perspective of an index disease, and one or more comorbid diseases may typically 
be considered. These diseases may affect the course and treatment of the index 
disease to varying degrees (varied weight of connecting bars). This framework may 
create disjointed treatment plans for each of the diseases and become cumbersome 
in patients with several co-existing diseases.
Highly  prevalent  chronic  diseases  (heart  disease,  diabetes,  arthritis, 
chronic lower respiratory tract disease and stroke) are known to co-occur 
frequently with each other.30 Other less prevalent conditions still may occur 
frequently  in  combination  with  these  (congestive  heart  failure,  anemia, 
renal insufficiency, depression).31,32 While there are varying definitions in 
the medical literature, multimorbidity is defined here as the co-existence 
of two or more chronic conditions, where one is not necessarily more 
central than the others.4,33-35 Multimorbidity includes traditional diseases 
and syndromes but also may be extended to refer to conditions such as 
chronic bursitis of the hip, rotator cuff problems, dyspepsia, migraines, 
sleep disturbances, functional bowel syndrome or constipation, disability, 
falls, hearing impairment, and sarcopenia, for example.34 The pathophysiology 
of these diseases, syndromes, and conditions may overlap and the management 
of them may interact to varying degrees. The intersection of these factors 
occurs in a context of biological status and physiologic reserves, as well as 
psychological health. The ramifications of suffering from multimorbidity 
unfold for a person within social, educational, cultural, behavioral, economic 
and environmental circumstances, which in turn affect management. While 
considering all of these dimensions is essential for patient-centered care, 454  Public Health Reviews, Vol. 32, No 2
the best terms for considering how all of these affect clinical decision-
making is not known. Multimorbidity needs to be considered within the 
context of a person, or patient.25,35 The person with multimorbidity also has 
individual values and priorities for their life and healthcare, which need to 
be elicited and factored into treatment plans.  
The failure of healthcare to systematically match patient needs to best 
therapeutic practices partly reflects the challenges of creating an integrated 
clinical plan for people with multimorbidity.26 Clinical approaches often 
focus on one disease at a time or may fail to take into account the interactions 
between  the  patient  and  healthcare  system  that  become  increasingly 
important as individual reserves diminish and the intricacy and intensity of 
healthcare increases. 
Fig. 2. Conceptual Diagram of Multimorbidity within an Individual Person’s 
Circumstances and Preferences. The perspective of multimorbidity may be useful 
for  treating  patients  with  multiple  conditions.  Conditions  include  traditional 
diseases, but also may reflect conditions such as disability, falls, hearing impairment, 
and sarcopenia that fall outside the traditional disease model. These conditions may 
overlap to varying degrees. The intersecting conditions exist within a context of 
biological health and reserves, as well as the psychological circumstances of a 
person (i.e., positive affect). The multimorbid conditions also unfold for given 
people  within  their  social,  educational,  cultural,  economic  and  environmental 
circumstances, and these will affect management of the multimorbid conditions. 
The person with multimorbidity also has individual values and priorities for their 
life and healthcare, which need to be elicited and factored into treatment plans.Future of Multimorbidity Research  455
Multimorbidity affects the clinical complexity associated with clinical 
decision-making  and  the  healthcare  system  in  which  clinical  decision-
making occurs.31 Clinical complexity results from the factors or elements 
that should be reconciled or addressed when making decisions about a 
therapeutic  strategy  or  prevention  strategy.  Because  there  is  a  lack  of 
agreement  on  definitions  of  complexity  and  not  all  current  definitions 
include  non-medical  dimensions,  this  term  may  be  challenging.36  For 
people with multimorbidity, the essential element is that decisions must be 
made within the context of a person (see Figure 2). Some decisions may be 
reducible to a single decision (i.e., Will a statin benefit this patient, and is 
she willing and able to take it?) but more commonly they involve several 
clinical questions at the same time (Should a patient start a statin, anti-
depressant, and pursue rehabilitation?). The latter scenario implies the need 
for prioritization – i.e., what is most important if not everything can be 
done and what should be done first if everything cannot or should not be 
done  at  one  time.  Some  co-occurring  conditions  may  be  managed 
synergistically (i.e., the use of ace inhibitors for diabetes and hypertension), 
and guidelines and quality standards sometimes recognize this overlap of 
clinical management. These conditions are thus concordant.29,37 Discordant 
conditions are more likely to add to the complexity of clinical decision-
making. The care of people with multimorbidity is failed by approaches 
that do not look at more than one factor or dimension and that may rely on 
conventional analytic techniques.38 
PEOPLE WITH MULTIMORBIDITY: PREVALENCE 
The prevalence of multimorbidity increases with age, but is not just an issue 
for older adults. As a result of advances in medical care and public health, 
a growing proportion of people have multimorbidity.39 In an Australian 
cohort study, more than 40 percent of the people with multimorbidity were 
less than 60 years of age.40 The prevalence of multimorbidity is striking in 
studies conducted in several countries in different parts of the world.1-
3,11,12,30,39,41-49  While  the  prevalence  varies,  this  partially  depends  on  the 
source of the population studied (patients vs. population based samples), 
sources  of  data  (e.g.,  surveys,  chart  reviews,  administrative  data),  data 
collection methods, targeted age groups, diagnoses considered and study 
populations,  making  the  comparability  of  prevalence  estimates 
questionable.3 The presence of multimorbidity also indicates higher risk of 
additional conditions; people with multimorbidity are at a higher risk of 
being diagnosed with two or more new diseases than those with no disease.14 456  Public Health Reviews, Vol. 32, No 2
Multimorbidity  is  even  more  important  when  each  condition  may 
influence  the  care  of  the  other  condition(s)  through  limitations  of  life 
expectancy, interactions between therapies, and/or direct contraindications 
to therapy for one condition by other conditions themselves.23,25,36 Forty-
eight percent of older adults have three or more chronic conditions.1 In 
younger populations, 35 percent of disabled adults have three or more 
chronic conditions.50 Among children, where the definition of a chronic 
health condition is less clear, prevalence estimates range from less than one 
percent up to 44 percent of children having multimorbidity.51 
It can be useful to think about the prevalence of multimorbidity with 
varied approaches. While it is important to note how many people have 
multimorbidity, and which specific conditions they have, it is also worth 
considering reporting data in different ways. For example, among older 
women participating in the United States nationally representative survey 
NHANES, examining five major chronic diseases (coronary heart disease, 
stroke, diabetes mellitus, arthritis, and chronic lower respiratory tract disease) 
with pattern analyses reveals that less than 20 percent of people with coronary 
heart disease have that disease alone, and not one of the other four conditions. 
Similar findings for how often the disease occurs in isolation were found for 
stroke, diabetes mellitus, and chronic lower respiratory tract disease (all less 
than 20 percent of the population with each condition, respectively). For 
arthritis, the prevalence of arthritis alone was 47 percent.30 These numbers 
would be smaller if a larger pool of conditions was considered. This work 
demonstrates that multimorbidity is the norm, not the exception, for many 
chronic diseases, and may speak to researchers, disease managers, policy 
makers and providers who have traditionally taken an index disease approach. 
Researchers have investigated whether specific conditions “cluster,” or occur 
together at greater rates than would be expected by chance alone.41,52 Such 
work  highlights  the  need  to  understand  the  underlying  pathogenesis  of 
multimorbidity, and may identify targets for preventive approaches.
IMPACT OF MULTIMORBIDITY ON PEOPLE
Multimorbidity affects QOL, ability to work and employability, disability 
and mortality.4,6-22,42,53-56 The relationship between multimorbidity and QOL 
is inverse, and the relationship to specific dimensions of QOL is complex.56 
Some  specific  chronic  conditions  have  a  stronger  relationship  with 
functional status than others, and there may be interaction between specific 
conditions, with the risk of disability in people with specific combinations 
of conditions greater than expected based on risks associated with the Future of Multimorbidity Research  457
individual conditions alone.18,57 The accumulation of new chronic conditions 
is associated with greater disability.58
PEOPLE WITH MULTIMORBIDITY AND THEIR FAMILY/SOCIAL 
SUPPORTS 
People living with multimorbidity have greater self-care needs.59-65 Complex 
older patients are especially likely to rely on and be affected by caregiver 
involvement  in  health  management.66  Family  involvement  is  a  key 
dimension  of  patient-centered  care  and  several  studies  substantiate  its 
influence on adherence.67-72 Aside from their role in dementia care and 
inpatient settings and with children, the role of caregivers has not been well 
articulated  in  chronic  care  initiatives,  but  their  role  is  increasingly 
recognized, particularly for people with multimorbidity.66,73-75 Caregivers 
are thus crucial to include in healthcare, public health policy initiatives, 
health system design, and research on people with multimorbidity. Many 
important  questions  remain  unanswered  in  terms  of  how  to  optimally 
integrate caregivers to improve the health of people with multimorbidity.76 
PEOPLE WITH MULTIMORBIDITY AND CURRENT HEALTH 
SYSTEMS
Patients with multimorbidity and complex healthcare needs often receive 
care that is fragmented, incomplete, inefficient, and ineffective.11,23,48,77,78 
For example, in addition to associations with high costs and utilization, the 
risk  of  potentially  avoidable  inpatient  admissions  or  preventable 
complications in an inpatient setting increases dramatically with the number 
of chronic conditions among older adults.48,49 Patients with multimorbidity 
may  be  particularly  susceptible  to  the  hazards  of  hospitalization, 
polypharmacy, and post-operative complications.79-81
HOW SHOULD AN UNDERSTANDING OF MULTIMORBIDITY 
INFORM HEALTH SYSTEM DESIGN?
An essential element of health system design that addresses people with 
multimorbidity is the elimination of the single disease focus. We want to take 
care of people with multimorbidity, not the individual conditions that add up 
to multimorbidity. Assuming that an additive process of the single disease 
approach will meet the needs of people with multimorbidity is flawed and 458  Public Health Reviews, Vol. 32, No 2
may even be harmful in many instances. Our health system should focus on 
people with multimorbidity, and recognize that some of the issues we must 
address are consequences of the multimorbidity and not diseases per se, but 
may have further adverse effects themselves. For example, polypharmacy is 
associated with greater rates of adverse events and drug interactions. Falls 
are most often multi-factorial in etiology, and yet can have dramatic impact 
on patient important outcomes like function and independence. For both of 
these examples, evidence-based interventions have been shown to improve 
patient important outcomes, and yet, neither is considered a “disease”.82,83 
Throughout healthcare, the disease-based focus prevails, from the design of 
clinical trials to the reimbursement structure in many countries.84
The Chronic Care Model
The Chronic Care Model (Figure 3), as described by Wagner et al., provides 
many of the essential elements of a healthcare system optimally designed 
for people with MCC.85 It is important to view this model and how it applies 
from the perspective of multimorbidity, not only a single-disease focus. 
Many interventions that derived from this model and approach have started 
with a focus on single conditions, but in recent years, there have been an 
increasing number of interventions that recognize that most people with 
one chronic disease have others.78,86-92
Fig. 3. The Chronic Care Model.
Source:  Copyright  1996-2010  The  MacColl  Institute  (with  permission).  The 
Improving Chronic Illness Care program is supported by The Robert Wood Johnson 
Foundation, with direction and technical assistance provided by Group Health’s 
MacColl Institute for Healthcare Innovation. Future of Multimorbidity Research  459
Patient-Centered Care
Primary care (or generalist care) is essential when considering how a health 
system should care for people with multimorbidity. Patient-centered care 
for patients with chronic illness is care which (1) is attentive to patient’s 
psychosocial as well as physical needs, (2) explores the patient’s concerns 
and priorities for care, (3) conveys a sense of partnership between the patient 
and physician, (4) facilitates active patient involvement in decision making, 
and  (5)  is  coordinated  across  professionals,  facilities,  and  support 
systems.93,94 This type of patient-centered care in a “medical home” may not 
need to be provided by a generalist or primary care provider, but should 
include the essential elements of a holistic approach to these patients and 
their healthcare and not focus inappropriately on one condition over others.94 
In some instances, one condition may be dominant, or be so complex or 
serious that it eclipses the management of other conditions either in the 
short-term or over the long-term.29 As described by Piette and Kerr, examples 
of this would include end-stage disease, severely symptomatic, or recently 
diagnosed conditions. When one condition is not dominant, patient-centered 
care would ideally balance all of a person’s conditions and allow for an 
integrated approach to their healthcare. This presents enormous challenges, 
as work by Yarnall et al. and Ostbye et al. demonstrates that a typical family 
practitioner in the US with a standard panel would not have adequate time 
in a typical day to deliver the services currently recommended for chronic 
disease management or preventive services.95,96 This work highlights two 
issues.  First,  the  responsibility  for  patient  education  and  follow-up of 
protocols and guidelines should be shared within an integrated healthcare 
system and community-based health programs to also engage physician 
assistants,  nurse  practitioners,  professional  and  neighborhood  health 
educators to provide education, counseling, and guidance.97-99 Second, the 
generation  of  evidence,  the  synthesis  of  evidence  in  guidelines,  the 
development  of  quality  standards,  and  the  setting  of  healthcare  system 
policy need to account for these issues, and prioritize across conditions and 
approaches to healthcare for those elements that are most important for 
improving the well-being of people with multimorbidity.26,96
Sites of Care and Transitions Between Them
People with multimorbidity are seen frequently, and in multiple sites of 
care, including emergency rooms, hospitals, outpatient settings, specialty 
clinics,  nursing  home  and  rehabilitation  facilities,  assisted  livings,  and 
home  healthcare.  People  with  multimorbidity  are  thought  particularly 
vulnerable to suboptimal quality care.1,100 Central then to the design of care 460  Public Health Reviews, Vol. 32, No 2
for these patients is the communication and connections between these 
traditional silos of care. Patients with multimorbidity may be most vulnerable 
to the adverse consequences of transitions of care, and thus the optimal 
health system would allow for facile communication across sites of care to 
avoid  duplicate  testing  which  may  be  harmful,  allow  for  medication 
reconciliation,  and  transfer  of  essential  information  about  allergies, 
medication, recent and past history, decision-making capabilities and contact 
information for healthcare agents (surrogates). Work on transitional care has 
included both disease specific approaches and those that do not focus on a 
particular condition.100-105 However, much of this work has focused on the 
transitions between the hospital and post-hospital settings, but transitions 
between outpatient providers may be equally important for the long-term 
management of people with multimorbidity.
Reimbursement Structure
Reimbursement systems are varied across countries, and often even within 
the same country. Therefore, we will focus on identification of general 
principles for reimbursement structures considering the design of health 
systems and people with multimorbidity. 
The goals of structuring a reimbursement system include the following 
key issues. These are not meant to be exhaustive in terms of considering all 
of the goals of reimbursement systems, but rather those issues that are 
particularly salient to people with multimorbidity. 
•    To encourage providers to want to care for people with multimorbidity 
(as opposed to avoiding them). 
•    To reward the cognitive processes and shared decision-making believed 
very important in making thoughtful, patient-centered decisions about 
healthcare.
•    To reward the cognitive aspects of medicine, not just procedures and 
technology. 
•    To minimize overuse and underuse of therapies and maximize appropriate 
use.
•    To attract adequate numbers of highly qualified individuals to primary 
care or care of people with multimorbidity.
•    To reward a patient – and family – centered approach over a disease 
based-approach (with incentives based largely on disease specific quality 
standards). 
•    To reward care coordination and communication between providers across 
sites of care, as well as with patients and families.Future of Multimorbidity Research  461
It is critical that the effects of changes to reimbursement systems be 
rigorously evaluated, particularly in regards to the most vulnerable populations, 
which include those living with multimorbidity. While there are many success 
stories,106 there are also many examples of unintended consequences resulting 
from  changes  in  how  we  approach  the  reimbursement  structures  for 
healthcare.107-111
Role of Family and Friends
While the importance of family and friends in chronic care has been increasingly 
recognized, the optimal ways to engage family members in the care of people 
with multimorbidity are not yet known, yet many of these patients are likely to 
be accompanied to medical visits, and many of these medical visit companions 
likely  assume  roles  in  the  management  of  healthcare  tasks  for  these 
people.66,76,112-114 The term “patient- and family-centered care” is increasingly 
used, but it is yet to be a reality in many chronic care outpatient settings.115,116
Clinical Practice Guidelines
Table 1
Summary of Review of CPGs Applicability to Older Adults with Multimorbidity
Issue
Number  
of CPGs 
addressing  
the issue
Quality of evidence for older adults with multimorbidity 2/9
Guidance on treatment of index condition in context of single comorbid 
condition
7/9
Guidance  on  treatment  of  index  condition  in  context  of  multiple 
comorbid conditions
4/9***
Information on time needed to treat in order to achieve benefit 1/9
Discussion of QOL issues 7/9*
Discussion of short-term vs. long-term goals 0/9
Recommendations for incorporating patient preferences 7/9**
* for two of these, QOL is addressed for only a single symptom119,120
** patient preferences are discussed only in regard to end-of-life for the congestive heart 
failure CPG119
*** guidance given for three of these conditions is only for multiple cardiovascular conditions 
Source: Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines 
and quality of care for older patients with multiple comorbid diseases: Implications for pay for 
performance. JAMA. 2005;294:716-24.26462  Public Health Reviews, Vol. 32, No 2
The applicability of clinical practice guidelines (CPGs) to older adults with 
multimorbidity  is  limited.26,117,118  A  review  of  nine  common  chronic 
conditions and selected primary care and specialty CPGs recommended by 
national or international organizations demonstrated inadequate attention 
to  this  population.26  The  CPGs  were  abstracted  by  two  reviewers  for 
components relevant to the care of older patients with multimorbidity. Thus 
as shown in Table 1, few of the nine CPGs address these issues of high 
relevance for older adults, particularly those with multiple conditions, and 
none of the guidelines that were reviewed comprehensively addressed these 
issues.
Applying relevant CPGs to a hypothetical 79 year old woman with 
moderate  severity  osteoporosis,  osteoarthritis,  diabetes  mellitus, 
hypertension, and chronic obstructive pulmonary disease leads to a complex 
and potentially harmful treatment regimen.26 Implementing CPGs for these 
conditions, and choosing generic, long-acting drugs with the least side 
effects,  she  would  be  prescribed  12  unique  medications,  requiring  a 
complex  regimen  of  19  doses  of  medication  per  day,  and  14  non-
pharmacologic treatments (self-monitoring, diet, exercise, healthcare visits, 
and laboratory testing). There were many potential drug-condition, drug-
drug, and food-drug interactions. Non-pharmacologic recommendations 
also contradict. This work identifies a high level of complexity, cost, and 
potential burden for such a treatment regimen. Complete adherence would 
not be feasible for many multimorbid adults, and, as shown above, the 
evidence for effectiveness for this patient population is often lacking.26
With rare exceptions, guidelines focus on the management of a single 
disease, and do not address how to optimally integrate care for individuals 
whose multiple problems may make guideline-recommended management 
of any single disease impractical, irrelevant or even harmful.26,121 The root 
of this problem, however, is not narrowly confined to guideline development 
and application, but is inherent throughout the translational path from the 
generation of the evidence to the synthesis of the evidence upon which 
guidelines  depend.  Recently,  emphasis  has  been  placed  on  the  role  of 
“pragmatic” clinical trials to guide the care of real world populations. It is 
essential to note that without appropriate analytic techniques to account for 
heterogeneity  of  treatment  effect,  the  results  of  such  trials  may  be 
misleading  about  whether  specific  patients  benefit  more  or  less  from 
therapies than the average patient.122,123 Efforts are currently underway to 
increase  the  applicability  of  our  evidence-base  and  clinical  practice 
guidelines to people with multimorbidity.124,125Future of Multimorbidity Research  463
Quality Standards
The  applicability  of  current  CPGs  is  therefore  poor  for  patients  with 
multimorbidity.26  The  translational  path  culminating  with  guideline 
development for patients with multimorbidity is flawed and has implications 
for  the  development  and  application  of  performance  measures.  Basing 
standards for quality of care and pay for performance on existing CPGs 
could lead to inappropriate judgment of the care provided to individuals 
with multimorbidity and could create perverse incentives that emphasize 
the wrong aspects of care for this population and diminish rather than 
improve the quality of their care.26 Defining and measuring quality of care 
in a patient-centered manner is essential for complex patients.
Comprehensive consideration of these issues is important for a framework 
for measuring performance for people with multimorbidity. Performance 
measurement for patients with multimorbidity has not been adequately 
developed.126 Importantly, most research on quality of care in people with 
multimorbidity has not employed simultaneous assessment of both patient-
reported quality of care and technical quality of care. While disease-specific 
performance standards are achieved in many multimorbid adults, patient 
reports of quality of primary care may be worse.127-129 Limited prior work 
suggests that these two perspectives are often poorly correlated and that 
patient evaluations of care are critical in understanding performance.130,131 
However, existing tools do not adequately capture the needs and complexity 
of people with multimorbidity, and it is unknown how to best measure 
performance for these patients.132
Quality of care may be defined using the Institute of Medicine’s six 
aims for healthcare: safety, effectiveness, patient-centeredness, timeliness, 
efficiency, and equity.133 No one has developed and employed an assessment 
of multimorbidity-specific quality. Assessing Care of Vulnerable Elderly 
(ACOVE) measures and the Patient Assessment of Chronic Illness Care 
have been used to measure care for people with multimorbidity, but neither 
capture all of the elements important for performance for people with 
multimorbidity.134 Measurement of this comprehensive definition of quality 
of  care  would  ideally  capture  optimal  medical  decision  making  with 
treatment appropriately individualized based on preferences and a relevant 
evidence base, and minimize both underuse and misuse.29,60,126,135 Goals of 
care for individuals with multimorbidity include patient-centered care, with 
a well-informed patient and provider understanding his/her individualized 
risks and incorporating patient preferences. The goal is to avoid causing 
harm from adverse consequences of treatments, and to reduce morbidity 
and  mortality  without  compromising  function  while  maximizing  other 
patient-important outcomes.464  Public Health Reviews, Vol. 32, No 2
Patients with multimorbidity are seen in multiple sites of care and by 
multiple providers, and measurement of performance will need to address 
these  issues.136  Patients  with  multimorbidity  may  benefit  most  from 
processes that target the aggregate effect of multiple conditions, such as 
processes  related  to  reducing  polypharmacy,  fall  risk,  and  minimizing 
adverse drug reactions. Over time, the framework for thinking about all of 
a person’s conditions may need to vary, to recognize that severity, prognosis 
and symptom burden will change.29 Also, patients with multimorbidity 
often choose or need to involve family or friends in their healthcare and 
decision-making.66
Many patients with multimorbidity receive interventions for which there 
is little evidence of benefit and are at high risk for adverse health events. 
Performance measures are available for specific conditions and are sometimes 
used in patients with multimorbidity in the absence of evidence that they are 
appropriate, and further development is needed. Many conceptual issues in 
performance measurement for patients with multimorbidity require further 
development.
Approaches Specifically Using a Multimorbidity Perspective  
in Primary Care
A recent review of US models of care serving older adults with multimorbidity 
found  similarities  between  the  programs  including:  comprehensive 
assessment, development of a comprehensive care plan that incorporates 
evidence-based protocols, implementation of the plan over time, proactive 
monitoring of the patient’s clinical status and adherence to the care plan, 
coordination  of  primary  care,  specialty  care,  hospitals,  emergency 
departments,  skilled  nursing  facilities,  other  medical  institutions,  and 
community agencies, facilitation of the patient’s transitions from hospitals 
to  post-acute  settings,  facilitation  of  the  patient’s  access  to  community 
resources, such as meals programs, handicapped-accessible transportation, 
adult  day  care  centers,  support  groups,  and  exercise  programs.77  Key 
differences between the programs reviewed include the year in which the 
program began, whether an established physician or new physician was 
involved,  the  type  of  setting  where  it  was  provided,  eligibility  for  the 
program, the frequency of contact, and reimbursement structures.106,137-139 
International work has identified other models with promise.140-143 Much 
work is needed in this area, particularly to understand the optimal health 
systems for younger people with multimorbidity, as well as how to transform 
typical primary care practices to meet these needs. In addition, little is 
known about how community, neighborhoods, and environments can best Future of Multimorbidity Research  465
support people with multimorbidity, although information from the broader 
chronic disease literature is potentially informative for understanding the 
necessary research agenda. 
CONCLUSION
The consideration of people with multimorbidity is essential in the design 
and evaluation of health systems. Fundamentally, people with multimorbidity 
should receive a patient- and family-centered approach to care throughout 
the health system, and understanding how to deliver this type of care in 
effective and efficient ways is an enormous challenge, and opportunity, for 
clinicians, researchers, and policy makers today. 
Acronyms list:
MCC = Muliple chronic condiditons
QOL = Quality of life
CPGs = Clinical practice guidelines 
Terms and definitions list: 
Multimorbidity: The co-existence of two or more chronic conditions, where one is 
not necessarily more central than the others.
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